| ICI | Immune checkpoint inhibitor |
| IRAE | Immune-related adverse event |
| MACE | Major adverse cardiac event |
| CMR | Cardiovascular magnetic resonance imaging |
| NSCLC | Non-small-cell lung cancer |
| ICI | Immune checkpoint inhibitor |
| IRAE | Immune-related adverse event |
| MACE | Major adverse cardiac event |
| CMR | Cardiovascular magnetic resonance imaging |
| NSCLC | Non-small-cell lung cancer |